dpp-4_inhibitors [TUSOM
US$ 22.87
who discovered glp-1 JCI Scientists Who Pioneered GLP-1 Drugs
Description
125 There is some evidence to support a role for increased dopaminergic activity
We dig into this and more in this article
These appetite-suppressing effects have contributed to the increasing use of GLP-1RAs in obesity management [57,58]
Tirzepatide (Mounjaro) Tirzepatide is unique because it targets two hormones: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)
Experimental evidence clearly demonstrates that GLP-1RAs such as liraglutide and semaglutide enhance AMPK activity, leading to increased expression of genes involved in mitochondrial fatty acid oxidation and diminished lipogenesis (12, 13)
